Stocks · Health care · Pharmaceutical Preparations

Immuneering Corp

IMRX Clue Score35
United States Fiscal year ends December CIK 0001790340 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Benjamin J. Zeskind
22 Dec 2022
President and CEO
Exercised, kept
2,500
$3.01
$7.53K
Benjamin J. Zeskind
12 Apr 2022
President and CEO
Exercised, kept
2,000
$3.01
$6.02K
Benjamin J. Zeskind
28 Feb 2022
President and CEO
Exercised, kept
2,000
$3.01
$6.02K

What was left out

Form 4 filings counted 143
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 2,718,177
History held since 30 Jul 2021